The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
出版年份 2019 全文链接
标题
The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer’s Disease Patients and Its Consequence to Oxidative Stress Biomarkers
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-08-28
DOI
10.3389/fphar.2019.00943
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
- (2018) C. Cheignon et al. Redox Biology
- Cognitive decline in normal aging and its prevention: a review on non-pharmacological lifestyle strategies
- (2017) Blanka Klimova et al. Clinical Interventions in Aging
- A novel oxidative stress marker in patients with Alzheimer’s disease: dynamic thiol–disulphide homeostasis
- (2016) Sadiye Gumusyayla et al. ACTA NEUROPSYCHIATRICA
- Non-Pharmacological Approaches to the Prevention and Treatment of Alzheimer's Disease with Respect to the Rising Treatment Costs
- (2016) Blanka Klimova et al. Current Alzheimer Research
- Dysfunction of NMDA receptors in Alzheimer’s disease
- (2016) Yan Zhang et al. NEUROLOGICAL SCIENCES
- Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy
- (2016) Martin Valis et al. NEUROTOXICITY RESEARCH
- A novel oxidative stress marker in patients with Alzheimer’s disease: dynamic thiol–disulphide homeostasis
- (2016) Sadiye Gumusyayla et al. ACTA NEUROPSYCHIATRICA
- Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
- (2015) Bruno Fonseca-Santos et al. International Journal of Nanomedicine
- Efficacy and adverse effects of memantine treatment for Alzheimer’s disease from randomized controlled trials
- (2015) Jue Jiang et al. NEUROLOGICAL SCIENCES
- Memantine Monotherapy for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
- (2015) Shinji Matsunaga et al. PLoS One
- Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer’s Disease: Understanding the Therapeutics Strategies
- (2014) Pradip K. Kamat et al. MOLECULAR NEUROBIOLOGY
- Population Pharmacokinetic Study of Memantine: Effects of Clinical and Genetic Factors
- (2013) Muriel Noetzli et al. CLINICAL PHARMACOKINETICS
- Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
- (2013) Muriel Noetzli et al. CLINICAL PHARMACOKINETICS
- Protective Effects of Memantine Against Methylmercury-Induced Glutamate Dyshomeostasis and Oxidative Stress in Rat Cerebral Cortex
- (2013) Wei Liu et al. NEUROTOXICITY RESEARCH
- Oxidative Stress and the Pathogenesis of Alzheimer's Disease
- (2013) Yan Zhao et al. Oxidative Medicine and Cellular Longevity
- Dysregulation of synaptic and extrasynaptic N-methyl-D-aspartate receptors induced by amyloid-β
- (2013) Zhi-Cong Wang et al. Neuroscience Bulletin
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- Role of organic cation transporters in drug-induced toxicity
- (2011) Giuliano Ciarimboli Expert Opinion on Drug Metabolism & Toxicology
- EFNS guidelines for the diagnosis and management of Alzheimer’s disease
- (2010) J. Hort et al. EUROPEAN JOURNAL OF NEUROLOGY
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer’s disease
- (2008) M. A. Korolainen et al. ACTA NEUROLOGICA SCANDINAVICA
- Pharmacodynamics of Memantine: An Update
- (2008) C. Parsons et al. Current Neuropharmacology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation